華測導航(300627.SZ)正籌劃非公開發行股票事項
格隆匯 7 月 2日丨華測導航(300627.SZ)公佈,為深化公司主業的前瞻性佈局,加強研發投入,進一步保持並提升公司競爭力,使公司持續創新發展,優化資本結構,促進公司高質量發展,以良好業績回報投資者,公司正在籌劃非公開發行股票事項。
此次非公開發行的股票數量按照募集資金總額除以發行價格確定,且不超過此次發行前總股本的30%,最終以本次發行申請通過深圳證券交易所審核並經中國證券監督管理委員會作出予以註冊決定後,由公司董事會根據公司股東大會的授權及發行時的實際認購情況,與此次發行的保薦機構(主承銷商)協商確定。此次發行預計不會導致公司控制權發生變化。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.